AUTOTRAINING USING SUSTAINABLE DIGITAL TECHNOLOGIES: MYTH OR REALITY



An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries

Abstract Background The Canadian government has committed to developing a national strategy for drugs for rare diseases starting in 2022.Considering this announcement, we conducted a comparative analysis to examine patient access to therapies for rare disease in Canada relative to Europe and the U.S.Methods Given its similarity to the Canadian heal

read more